Trial: 202005010

FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE

Phase

II

Principal Investigator

Frith, Ashley

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov